Abstract:Despite recent insights gained from the effects of targeted deletion of the Finkel-Biskis-Jinkins osteosarcoma oncogene (c-fos), Spleen focus-forming virus (SFFV) proviral integration 1 (PU.1), microphthalmia- associated transcription factor, NF-kappa B, and nuclear factor of activated cells cytoplasmic 1 (NFATc1) transcription factor genes, the mechanism underlying transcription factors specifying osteoclast (OC) lineage commitment from monocyte/macrophage remains unclear. To characterize the mechanism by which transcription factors regulate OC lineage commitment, we mapped the critical cis-regulatory element in the promoter of cathepsin K (Ctsk), which is expressed specifically in OCs, and found that CCAAT/enhancer binding protein alpha (C/EBP alpha) is the critical cis-regulatory element binding protein. Our results indicate that C/EBP alpha is highly expressed in pre-OCs and OCs. The combined presence of macrophage colony-stimulating factor and receptor activator of NF-kappa B ligand significantly induces high C/EBP alpha expression. Furthermore, C/EBP alpha(-/-) newborn mice exhibited impaired osteoclastogenesis, and a severe osteopetrotic phenotype, but unaffected monocyte/macrophage development. Impaired osteoclastogenesis of C/EBP alpha(-/-) mouse bone marrow cells can be rescued by c-fos overexpression. Ectopic expression of C/EBP alpha in mouse bone marrow cells and monocyte/ macrophage cells, in the absence of receptor activator of NF-kappa B ligand, induces expression of receptor activator of NF-kappa B, c-fos, Nfatc1, and Ctsk, and it reprograms monocyte/ macrophage cells to OC-like cells. Our results demonstrate that C/EBP alpha directly up-regulates c-fos expression. C/EBP alpha(+/-) mice exhibit an increase in bone density compared with C/EBP alpha(+/+) controls. These discoveries establish C/EBP alpha as the key transcriptional regulator of OC lineage commitment, providing a unique therapeutic target for diseases of excessive bone resorption, such as osteoporosis and arthritis.

β-Catenin/LEF1 activated enamelin expression in ameloblast-like cells

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Constitutive activation of β-catenin in ameloblasts leads to incisor enamel hypomineralization

[Enamelin Transcriptional Expression in Developing Postnatal Rat Tooth Germ].

Putative Signaling Action of Amelogenin Utilizes the Wnt/Beta-Catenin Pathway

[Expression Patterns of Amelogenin and Enamelin in Developing Mouse Tooth Germs].

[Relationship Between Sp3 and the Transcriptional Regulation of Enamelin Gene].

ENAM gene associated with T classification and inhibits proliferation in renal clear cell carcinoma

Interleukin-8/β-catenin mediates epithelial-mesenchymal transition in ameloblastoma.

In vivo Overexpression of Tuftelin in the Enamel Organic Matrix

Persistent Wnt/β-catenin Signaling in Mouse Epithelium Induces the Ectopic Dspp Expression in Cheek Mesenchyme.

The Transcription Factor AmeloD Stimulates Epithelial Cell Motility Essential for Tooth Morphology.

[Immunohistochemical Localization of Enamelin in Developing Rat Tooth Germ].

Identification of a face enhancer reveals direct regulation of LIM homeobox 8 (Lhx8) by wingless-int (WNT)/β-catenin signaling

ENH Promotes Vascular Remodeling As a Negative Regulator of AKT Activation in Mouse Endothelium

[Construction of the Stable Cell Line Expressing the Mouse Recombinant Enamelin Gene].

A N‐Terminus Domain Determines Amelogenin's Stability to Guide the Development of Mouse Enamel Matrix

Co-Immunoprecipitation Reveals Interactions Between Amelogenin and Ameloblastin via Their Self-Assembly Domains

Ameloblastin Binds to Phospholipid Bilayers via a Helix-Forming Motif within the Sequence Encoded by Exon 5

Stage-Specific Role of Amelx Activation in Stepwise Ameloblast Induction from Mouse Induced Pluripotent Stem Cells

β-catenin mediates endodermal commitment of human ES cells via distinct transactivation functions